Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Amineptine

An atypical tricyclic antidepressant developed in France in the 1960s and introduced in 1978 for severe depression; unlike other tricyclics it acts mainly on dopamine. Its French authorisation was suspended in 1999. This family brings together the active ingredient and other impurities.

Did you know?In animal studies it promotes wakefulness, so much so that it has been suggested as a possible treatment for narcolepsy; its side chain ends in a seven-carbon acid.

AmineptineGo to the active ingredient →
AmineptineActive ingredientAmineptineCat. No. P-A121-001CAS 57574-09-1

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.